BioCryst Pharmaceuticals
BCRX
#4517
Rank
A$3.30 B
Marketcap
A$13.17
Share price
-2.38%
Change (1 day)
13.41%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): A$0.39 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are A$0.87 Billion. , an increase over its 2024 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 A$0.37 B-407.51%
2024 -A$0.13 Billion-61.56%
2023 -A$0.32 Billion-7.43%
2022 -A$0.35 Billion34.42%
2021 -A$0.26 Billion-0.55%
2020 -A$0.26 Billion67.88%
2019 -A$0.16 Billion7.55%
2018 -A$0.15 Billion53.92%
2017 -A$91.77 Million19.29%
2016 -A$76.93 Million28.19%
2015 -A$60.02 Million-4.8%
2014 -A$63.04 Million50.09%
2013 -A$42.01 Million-23.29%
2012 -A$54.76 Million-26.19%
2011 -A$74.19 Million54.78%
2010 -A$47.93 Million150.1%
2009 -A$19.17 Million-49.43%
2008 -A$37.9 Million14.07%
2007 -A$33.22 Million-49.31%
2006 -A$65.54 Million72.87%
2005 -A$37.92 Million22.08%
2004 -A$31.06 Million75.3%
2003 -A$17.72 Million-25.36%
2002 -A$23.74 Million225.05%
2001 -A$7.31 Million-56.6%
2000 -A$16.83 Million50.63%
1999 -A$11.17 Million38.05%
1998 -A$8.1 Million-52.46%
1997 -A$17.02 Million58.44%
1996 -A$10.75 Million-14.44%
1995 -A$12.56 Million28.57%
1994 -A$9.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$13.66 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.80 B 3,600.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-A$0.36 Billion-194.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$0.11 B-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$0.52 B 40.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.41 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.34 Million-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$34.55 Million-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA